Gleevec a cancer drug that costs US$70,000 in the U.S. per year, cost just US$2,500 in India because it can't be patented there. - Study24x7
Social learning Network
12 Apr 2019 09:22 AM study24x7 study24x7

Gleevec a cancer drug that costs US$70,000 in the U.S. per year, cost just US$2,500 in India because it can't be patented there.

study24x7
Write a comment
Related Questions
500+   more Questions to answer
Most Related Articles